Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Cash from Operations (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Cash from Operations readings, the most recent being 9895000.0 for Q4 2023.

  • On a quarterly basis, Cash from Operations fell 36.0% to 9895000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was 32694000.0, a 47.41% decrease, with the full-year FY2025 number at 36952000.0, changed 0.31% from a year prior.
  • Cash from Operations hit 9895000.0 in Q4 2023 for Elicio Therapeutics, down from 5185000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 20591000.0 in Q4 2020 to a low of 21942000.0 in Q3 2020.
  • Median Cash from Operations over the past 4 years was 9685000.0 (2023), compared with a mean of 8150250.0.
  • Biggest five-year swings in Cash from Operations: surged 158.27% in 2022 and later plummeted 254.42% in 2023.
  • Elicio Therapeutics' Cash from Operations stood at 20591000.0 in 2020, then tumbled by 169.75% to 14362000.0 in 2021, then skyrocketed by 49.34% to 7276000.0 in 2022, then crashed by 36.0% to 9895000.0 in 2023.
  • The last three reported values for Cash from Operations were 9895000.0 (Q4 2023), 5185000.0 (Q3 2023), and 9475000.0 (Q2 2023) per Business Quant data.